Goldman Sachs
BLUE

Goldman Sachs’s bluebird bio BLUE Stock Holding History

Goldman Sachs’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,162
Closed -$4.78M – 5660
2018
Q1 		$4.78M Sell
2,162
-772
-26% -$1.96M ﹤0.01% 2929
2017
Q4 		$6.77M Buy
2,934
+2,162
+280% +$4.39M ﹤0.01% 2752
2017
Q3 		$1.37M Buy
+772
New +$1.08M ﹤0.01% 4309
2017
Q2 		– Sell
-1,760
Closed -$2.07M – 6769
2017
Q1 		$2.07M Buy
+1,760
New +$1.8M ﹤0.01% 3712
2016
Q2 		– Sell
-1,428
Closed -$786K – 7022
2016
Q1 		$786K Sell
1,428
-888
-38% -$545K ﹤0.01% 4304
2015
Q4 		$1.93M Sell
2,316
-9,665
-81% -$9.66M ﹤0.01% 3665
2015
Q3 		$13.3M Buy
11,981
+10,437
+676% +$19M ﹤0.01% 2025
2015
Q2 		$3.37M Hold
1,544
– – ﹤0.01% 3321
2015
Q1 		$2.42M Sell
1,544
-5,234
-77% -$6.91M ﹤0.01% 3592
2014
Q4 		$8.05M Sell
6,778
-11,094
-62% -$7.41M ﹤0.01% 2529
2014
Q3 		$8.31M Buy
17,872
+13,811
+340% +$6.37M ﹤0.01% 2525
2014
Q2 		$2.03M Buy
+4,061
New +$1.3M ﹤0.01% 3986

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Goldman Sachs's BLUE Position: Q2 2025 in Review

Goldman Sachs sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 64,950 shares — an estimated $317K sold.

Goldman Sachs first reported a position in BLUE in Q3 2013 and held it in 46 quarters. The position peaked at $130M in Q2 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Goldman Sachs reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Goldman Sachs sold 64,950 bluebird bio shares in Q2 2025, an estimated $317K.
  • Goldman Sachs first reported a position in bluebird bio in Q3 2013 and held it in 46 quarters.
  • Goldman Sachs's bluebird bio position peaked at $130M in Q2 2018.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Goldman Sachs's 13F filing for Q2 2025, filed 14 Aug 2025.